Literature DB >> 6935296

Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody.

J M Pesando, J Ritz, H Lazarus, K J Tomaselli, S F Schlossman.   

Abstract

Modulation of a human common acute lymphoblastic leukemia antigen (CALLA) by specific monoclonal antibody (J5) has been studied with the immune precipitation method to identify radiolabeled antigen. Surfaces of leukemic cells have been labeled using 125I both before and after modulation by J5 antibody for different time intervals. Leukemic cells have also been metabolically labeled with 35S-methionine before modulation. These studies indicate that the 100,000-dalton glycoprotein expressing CALLA (gp 100-CALLA) cannot be detected in cells that were modulated with J5 antibody before surface labeling but that it is easily detectable in cells that were surface labeled before modulation for 10 hr. At later time points, gp 100-CALLA is selectively lost from cells that were surface labeled before modulation. Gp 100-CALLA is not detected in the supernatants from cultures of these modulated cells. We conclude that gp 100-CALLA is rapidly internalized during modulation and that CALLA is degraded. Gp 100-CALLA is not shed into the culture media, nor does it remain on the cell surface in an altered form. Incubation of leukemic cells with antisera to beta2-microglobulin or IgM does not affect the expression of gp 100-CALLA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6935296

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Radioimmunotherapy in mantle cell lymphoma.

Authors:  Alan P Skarbnik; Mitchell R Smith
Journal:  Best Pract Res Clin Haematol       Date:  2012-05-09       Impact factor: 3.020

2.  HOCl exposure of a human airway epithelial cell line decreases its plasma membrane neutral endopeptidase.

Authors:  Z H Lang; C G Murlas
Journal:  Lung       Date:  1991       Impact factor: 2.584

3.  Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.

Authors:  W Tilgen; S Matzku; I Kaufmann; M Engstner; J Brüggen; W Dippold; D Petzoldt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Monoclonal antibodies in clinical medicine.

Authors:  H M Dick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

5.  Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.

Authors:  M Colombatti; C Bron
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

6.  Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.

Authors:  A K Singh; B S Kasinath
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

7.  Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.

Authors:  S M Hobbs; J M Styles; C J Dean; P S Shepherd
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

8.  Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy.

Authors:  K S Webb; J L Ware; S F Parks; W H Briner; D F Paulson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  Biological therapy of cancer.

Authors:  K A Foon
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

10.  Antibody-induced modulation of proteins in vesicular stomatitis virus-infected fibroblasts.

Authors:  E J O'Rourke; W H Guo; A S Huang
Journal:  Mol Cell Biol       Date:  1983-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.